35 related articles for article (PubMed ID: 33355904)
1. Preparation of Direct Healthcare Professional Communication: An Exploratory Study on the Experiences and Perceptions of European Pharmaceutical Companies and the EMA.
Boskovic A; Møllebæk M; Kaae S
Ther Innov Regul Sci; 2019 Sep; ():2168479019871041. PubMed ID: 31510799
[TBL] [Abstract][Full Text] [Related]
2. Additional safety risk to exceptionally approved drugs in Europe?
Arnardottir AH; Haaijer-Ruskamp FM; Straus SM; Eichler HG; de Graeff PA; Mol PG
Br J Clin Pharmacol; 2011 Sep; 72(3):490-9. PubMed ID: 21501215
[TBL] [Abstract][Full Text] [Related]
3. Comparative, cross-sectional study of the format, content and timing of medication safety letters issued in Canada, the USA and the UK.
Bjerre LM; Parlow S; de Launay D; Hogel M; Black CD; Mattison DR; Grimshaw JM; Watson MC
BMJ Open; 2018 Oct; 8(10):e020150. PubMed ID: 30297342
[TBL] [Abstract][Full Text] [Related]
4. A decade of safety-related regulatory action in the Netherlands: a retrospective analysis of direct healthcare professional communications from 1999 to 2009.
Mol PG; Straus SM; Piening S; de Vries JT; de Graeff PA; Haaijer-Ruskamp FM
Drug Saf; 2010 Jun; 33(6):463-74. PubMed ID: 20486729
[TBL] [Abstract][Full Text] [Related]
5. When direct health-care professional communications have an impact on inappropriate and unsafe use of medicines.
Reber KC; Piening S; Wieringa JE; Straus SM; Raine JM; de Graeff PA; Haaijer-Ruskamp FM; Mol PG
Clin Pharmacol Ther; 2013 Apr; 93(4):360-5. PubMed ID: 23443752
[TBL] [Abstract][Full Text] [Related]
6. Drug Safety Issues Covered by Lay Media: A Cohort Study of Direct Healthcare Provider Communications Sent between 2001 and 2015 in The Netherlands.
de Vries E; Denig P; de Vries ST; Monster TBM; Hugtenburg JG; Mol PGM
Drug Saf; 2020 Jul; 43(7):677-690. PubMed ID: 32212054
[TBL] [Abstract][Full Text] [Related]
7. Effect of safety issues with HIV drugs on the approval process of other drugs in the same class: an analysis of European Public Assessment Reports.
Arnardottir AH; Haaijer-Ruskamp FM; Straus SM; de Graeff PA; Mol PG
Drug Saf; 2011 Nov; 34(11):1101-14. PubMed ID: 21981437
[TBL] [Abstract][Full Text] [Related]
8. Preparation of Direct Healthcare Professional Communication: An Exploratory Study on the Experiences and Perceptions of European Pharmaceutical Companies and the EMA.
Boskovic A; Møllebæk M; Kaae S
Ther Innov Regul Sci; 2020 May; 54(3):631-639. PubMed ID: 33301149
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Unrounded Medication Doses and Associated Factors Among Hospitalized Pediatric Patients.
Jones AN; Miller JL; Neely S; Ibach BW; Hagemann TM; Golding CL; Lewis TV; Peek LA; Johnson PN
J Pediatr Pharmacol Ther; 2017; 22(4):286-292. PubMed ID: 28943824
[TBL] [Abstract][Full Text] [Related]
10. Dissemination of Direct Healthcare Professional Communications on Medication Errors for Medicinal Products in the EU: An Explorative Study on Relevant Factors.
Hoeve CE; de Vries E; Mol PGM; Sturkenboom MCJM; Straus SMJM
Drug Saf; 2021 Jan; 44(1):73-82. PubMed ID: 33355904
[TBL] [Abstract][Full Text] [Related]
11. Medication Errors: New EU Good Practice Guide on Risk Minimisation and Error Prevention.
Goedecke T; Ord K; Newbould V; Brosch S; Arlett P
Drug Saf; 2016 Jun; 39(6):491-500. PubMed ID: 26940903
[TBL] [Abstract][Full Text] [Related]
12. Initiatives to identify and mitigate medication errors in England.
Cousins D; Gerrett D; Richards N; Jadeja MM
Drug Saf; 2015 Apr; 38(4):349-57. PubMed ID: 25735854
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
